Journal of Neurovirology

Article	Citations
Possible role of CNS microRNAs in Human Mpox virus encephalitis—a mini-review	50
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report	47
Combined effects of older age and HIV disease on changes in everyday functioning over one year	34
Zika virus infection of retinal cells and the developing mouse eye induces host responses that contrasts to the brain and dengue virus infection	24
HIV associated motor neuron disease (MND): A case series with systematic review of literature	21
Cognitive function and impact on driving after SARS-COV-2 infection in a man with long-standing HIV infection: a case report	19
Serum mir-142-3p release in children with viral encephalitis and its relationship with nerve injury and inflammatory response	17
Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients	16
Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab	16
Varicella-zoster virus meningitis coincident with bacteremia caused by liver abscess: a case report	15
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats	15
Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women	14
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation	14
SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations	14
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma	14
HIV-1 and methamphetamine alter galectins -1, -3, and -9 in human monocyte-derived macrophages	13
COVID-19 leukoencephalopathy with subacute magnetic resonance imaging findings of vasculitis and demyelination	13
Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda	13
Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody	12
Effect of coinfections on neurocognitive functioning among people with clade C HIV infection in Zambia	12
SARS-CoV-2-associated haemorrhagic encephalitis mimicking Herpes encephalitis	12
Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study	12
Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals	11
Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected	11
Upregulation of microRNAs correlates with downregulation of HERV-K expression in Parkinson’s disease	11

Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases	11
HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis	11
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV	10
Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis	9
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice	9
A human-derived 3D brain organoid model to study JC virus infection	9
Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and Aβ40/42 alterations in serum and cerebrospinal fluid	8
Increased expression of PD-1 in CD8 + CD3 + T cells correlates with EBV viral load in MS patients	8
Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma	8
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study	8
A case of ischemic stroke secondary to varicella-zoster virus meningoencephalitis	8
Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases	8
Herpes simplex encephalitis in patients receiving chemotherapy and whole-brain radiation therapy	8
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers	8
Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good’s syndrome	8
Differential effects of fentanyl compared to morphine on neuroinflammatory signaling in the brain in EcoHIV-infected mice	7
Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis	7
Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus	7
Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis: a systematic review	7
Influence of plasma exosomes from women living with HIV Stratified by HAND on monocyte subpopulations from healthy women without HIV	7
A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature	7
HIV-associated multiple intracranial aneurysms and stroke in an adult patient: successful treatment with a combination of glucocorticoid and antiviral agents	7
In vitro characterization of the antiviral activity of Bat Interferon-Induced protein with tetratricopeptide repeats 5 (bat IFIT5) against bat-associated rabies virus	7
Cognitive deficits in HTLV-1 patients	6
Limited evidence for a moderating effect of HIV status on brain age in heavy episodic drinkers	6
Implications of vascular depression for successful cognitive aging in HIV Disease	6
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma	6
The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation	6
Characterizing Epstein-Barr virus infection of the central nervous system in Zambian adults living with HIV	6
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications	6
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system	6
Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy	6
Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report	6
Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells	5
The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV	5
HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes	5
Maintaining the battle against vaccine-preventable neurological diseases in the United States	5
Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature	5
Differential expression of cellular prion protein (PrPC) in mouse hepatitis virus induced neuroinflammation	5
The incidence of symptomatic CSF viral escape in patients on antiretroviral therapy in western India: a retrospective cohort study	5
Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use	5
Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country	5
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review	5
A pilot study of cognition and creativity among persons with HIV disease referred for neuropsychological evaluation	5
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis	5
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau	5
Response to “a fatal case of Guillain-Barré syndrome after infection with COVID-19”	4
Encephalomyelitis in a patient with monkeypox: an unusual complication	4
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid	4
Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations	4

Cooperative interactions between neurotrophin receptors and CXCR4 regulate macrophage phenotype and susceptibility to activation by HIV	4
Extensive longitudinal myelitis due to cytomegalovirus infection	4
Risk factors for neurological complications in children with Flavivirus infection	4
Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex	4
Monkeypox virus replication underlying circadian rhythm networks	4
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV	4
Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV	4
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology	4
Long-term sequelae of herpes simplex virus encephalitis–related white matter injury: correlation of neuropsychological outcome and diffusion tensor imaging	4
T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder	4
Artery of Percheron infarction associated with COVID-19 in the young adult	4
Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases	4
A viral attack on brain tumors: the potential of oncolytic virus therapy	4
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases	3
Persistent accelerated epigenetic ageing in a longitudinal cohort of vertically infected HIV-positive adolescents	3
Cognitive dysfunction following COVID-19 infection	3
Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report	3
Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR	3
SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell–derived human neurons	3
Reactivation of varicella zoster virus following trigeminal schwannoma resection	3
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis	3
Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate	3
Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants	3
High glucose potentiates Zika virus induced-astroglial dysfunctions	3
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells	3
Single nucleotide polymorphisms in aquaporin-4 associate with cognitive impairment status in people with HIV	3
Neuropsychiatric disorders in the course to SARS-CoV-2 virus infection, including biological pathomechanisms, psychosocial factors and long COVID-19 associated with “brain fog”	3
Is there a connection between neurocognitive profile in treatment naïve non-cirrhotic HCV patients and level of systemic inflammation?	3
Cerebrospinal fluid CD14++CD16+ monocytes in HIV-1 subtype C compared with subtype B	3
Immune-mediated cerebellitis following SARS-CoV-2 infection—a case report and review of the literature	3
Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression	3
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder	3
A frantic confusion: beyond rabies and anti-N-methyl-D-aspartate encephalitis	3
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV	3
Notes from guest editor Dr. Fatah Kashanchi	3
A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry	3
Sex differences in cognitive function among people with HIV-1 clade C infection in Northern India	3
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD4	3
The synergistic effect of insomnia and depression on risk of herpes zoster	3
Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV	3
Susac syndrome complicating a SARS-CoV-2 infection	3
Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice	3
RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection	3
Central nervous system reactivation of herpesviridae family in patients with COVID-19	3
Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital	3
Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) stu	3
Neuropsychological profile of patients with infectious disease: characterization and comparison of patients with HIV, HTLV, and HCV	3
Does antiretroviral therapy alter the course of Parkinson’s disease in people living with HIV?	3
Regulation of voltage-gated sodium channels by TNF-α during herpes simplex virus latency establishment	3
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro	3
Acute cerebellitis following COVID-19 infection associated with autoantibodies to glutamate receptors: a case report	3
Amebic infections of the central nervous system	3
Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches	3
Circulating endothelial and angiogenic cells predict hippocampal volume as a function of HIV status	2
Clinical use of steroids in viral central nervous system (CNS) infections: three challenging cases	2
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections	2
Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies	2
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial	2
Induced expression of rabies glycoprotein in the dorsal hippocampus enhances hippocampal dependent memory in a rat model of Alzheimer’s disease	2
HIV viremia contributes to neurocognitive impairments in persons who use cocaine	2
Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo	2
Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran	2
Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling	2
HIV peripheral neuropathy‐related degeneration of white matter tracts to sensorimotor cortex	2
Caffeine upregulates SIRT3 expression to ameliorate astrocytes-mediated HIV-1 Tat neurotoxicity via suppression of EGR1 signaling pathway	2
Multi-functional auto-fluorescent nanogels for theranostics	2
Risk factors of herpes simplex virus reactivation after surgery for primary trigeminal neuralgia	2
Correction: Performance of the national institute of infectious diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis	2
Assessing cognitive impairment in HIV-infected: a comparative study of international HIV Dementia Scale, HIV Dementia Scale Italian version and Montreal cognitive assessment in clinical practice	2
The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV	2
CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study	2
Norovirus-associated neurological manifestations: summarizing the evidence	2
The impacts of HIV infection, age, and education on functional brain networks in adults with HIV	2
Additive cortical gray matter deficits in people living with HIV who use cocaine	2
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature	2
Disruption of blood–brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins	2
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab	2
A case of trigeminal neuralgia developing after a COVID-19 vaccination	2
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology	2
Influenza vaccination status in multiple sclerosis patients from Latin America	2

Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder

2